MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Clinical trial NCT04013334 · UNKNOWN

Trial details

NCT number: NCT04013334
Sponsor: Momotaro-Gene Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2019-08-15
Primary completion: 2022-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.